$71.82
+1.68 (+2.40%)
CVS News8 articles
Salesforce Unveils AI Healthcare Agents, Stock Gains Amid Sector Competition
Salesforce introduced six new AI agents for healthcare workflows, with integrations from HealthEx, Verily, and Viz.ai. The company's stock climbed 3.8% as competitors AWS and Google Cloud announced similar healthcare AI platforms.
Technology
AWS Launches AI Platform to Automate Healthcare Administrative Tasks
Amazon's cloud division has unveiled Amazon Connect Health, an AI-driven platform aimed at reducing administrative burdens in healthcare by automating tasks like patient verification and clinical documentation. Early adopters report efficiency gains, with Amazon shares rising slightly on the news.
Technology
UnitedHealth Rallies Ahead of Key Medicare Decision
UnitedHealth Group shares closed 3.1% higher at $293.19 on Friday, marking a three-day rally. Investors are now focused on the upcoming final 2027 Medicare Advantage rate decision.
Regulation
UnitedHealth Gains Amid Medicare Rate Uncertainty and ACA Investigations
UnitedHealth shares edged higher as investors monitored upcoming Medicare Advantage payment decisions and a House Republican probe into ACA insurers. The sector traded mixed.
Regulation
UnitedHealth Dips After Hours as Medicare Rate Decision Looms
UnitedHealth shares edged lower in extended trading Monday as healthcare stocks underperformed the broader market. Investors are focused on upcoming Medicare Advantage reimbursement updates, with the final rates expected in early April.
Markets
Amgen Hits 52-Week Peak on Strong Earnings; Key Data, Dividend Date Ahead
Amgen shares surged 4.5% to a 52-week high of $384.32, fueled by robust quarterly results and a dividend declaration. Investors now await delayed U.S. jobs and inflation figures.
Earnings
UnitedHealth Rallies 3% to Close Volatile Week; Medicare Advantage Outlook in Focus
UnitedHealth shares gained 3% Friday to $276.65, stabilizing after a turbulent period for managed-care stocks. Investors now await earnings from CVS Health and Humana next week for critical updates on Medicare Advantage trends.
Markets
Amgen Reaches 52-Week Peak on Friday; Investors Eye Inflation Data and Drug Pricing
Amgen shares surged 4.5% to close at $384.32 on Friday, achieving a new 52-week high. Market participants are monitoring upcoming U.S. inflation figures and developments in drug pricing.
Markets